PHIO CEO Robert J. Bitterman Receives 400,000-Share Award

What Happened

• Robert J. Bitterman, Chairman, President & CEO of Phio Pharmaceuticals (PHIO), received an award of 400,000 shares via restricted stock units (RSUs) on 2026-09-28. The units were granted at $0.00 (no cash paid) and will convert to common stock upon vesting.

Key Details

• Transaction type: Award/Grant (Code A)
• Transaction date: 2026-09-28; Form 4 filed 2026-09-29 (within typical filing window)
• Shares granted: 400,000 RSUs; grant price: $0.00; reported value: $0
• Vesting: Per footnote, these RSUs vest on the first annual anniversary of the grant
• Footnotes: F1 = shares underlying RSUs vest on first anniversary; F2 = references inclusion of unvested RSUs in ownership reporting
• Shares owned after transaction: not specified in the provided excerpt

Context

• This was a compensation grant (RSUs), not an open-market purchase or sale; no immediate cash outlay or stock sale occurred. Such awards are common as executive compensation and do not by themselves indicate a buy/sell signal.